CRISPR Therapeutics AG (CRSP) R&D In Process (2025)
CRISPR Therapeutics AG's R&D In Process history spans 1 years, with the latest figure at $96.3 million for Q2 2025.
- For Q2 2025, R&D In Process changed N/A year-over-year to $96.3 million; the TTM value through Sep 2025 reached $96.3 million, changed N/A, while the annual FY2025 figure was $96.3 million, N/A changed from the prior year.
- R&D In Process for Q2 2025 was $96.3 million at CRISPR Therapeutics AG.
- Across five years, R&D In Process topped out at $96.3 million in Q2 2025 and bottomed at $96.3 million in Q2 2025.